ApprovalTrail

Company · Kirkland, Quebec, Canada

Upjohn Canada Ulc

Everything this company holds in Health Canada’s product databases, as the company’s name is spelled there.

Drug products (DIN)
3
0 authorized now
Natural health products
0
0 active licences
Medical device licences
0
0 active
Notices of Compliance
61

Drug products

Authorized products first.

NameDINStatus
LYRICA02268442Cancelled Pre Market
LYRICA02268469Cancelled Pre Market
NORVASC00878901Cancelled Pre Market

Notices of Compliance

Newest first.

  • GD-LATANOPROST/TIMOLOLSeptember 11, 2023 · NOC 31597 · Supplement to a New Drug Submission (SNDS)
  • GD-LATANOPROSTAugust 15, 2023 · NOC 31420 · Supplement to a New Drug Submission (SNDS)
  • ZOLOFTMay 9, 2023 · NOC 30683 · Supplement to a New Drug Submission (SNDS)
  • DILANTINMarch 3, 2023 · NOC 30242 · Supplement to a New Drug Submission (SNDS)
  • DILANTIN INFATABS; DILANTIN-125 SUSPENSION; DILANTIN-30 SUSPENSIONMarch 3, 2023 · NOC 30243 · Supplement to a New Drug Submission (SNDS)
  • NEURONTINFebruary 28, 2023 · NOC 30227 · Supplement to a New Drug Submission (SNDS)
  • NORVASCFebruary 24, 2023 · NOC 30203 · Supplement to a New Drug Submission (SNDS)
  • CADUETFebruary 22, 2023 · NOC 30197 · Supplement to a New Drug Submission (SNDS)
  • EFFEXOR XRFebruary 20, 2023 · NOC 30159 · Supplement to a New Drug Submission (SNDS)
  • ZOLOFTFebruary 16, 2023 · NOC 30135 · Supplement to a New Drug Submission (SNDS)
  • VIAGRAFebruary 14, 2023 · NOC 30121 · Supplement to a New Drug Submission (SNDS)
  • LIPITORFebruary 10, 2023 · NOC 30112 · Supplement to a New Drug Submission (SNDS)
  • CELEBREXFebruary 10, 2023 · NOC 30118 · Supplement to a New Drug Submission (SNDS)
  • DETROL LAJanuary 26, 2023 · NOC 29971 · Supplement to a New Drug Submission (SNDS)
  • DETROLJanuary 25, 2023 · NOC 29970 · Supplement to a New Drug Submission (SNDS)
  • XALATANJanuary 25, 2023 · NOC 29972 · Supplement to a New Drug Submission (SNDS)
  • XALACOMJanuary 25, 2023 · NOC 29973 · Supplement to a New Drug Submission (SNDS)
  • NEURONTINJanuary 3, 2023 · NOC 30049 · Supplement to a New Drug Submission (SNDS)
  • LYRICANovember 14, 2022 · NOC 29455 · Supplement to a New Drug Submission (SNDS)
  • RELPAXOctober 26, 2022 · NOC 29342 · Supplement to a New Drug Submission (SNDS)
  • ZOLOFTOctober 19, 2022 · NOC 29243 · Supplement to a New Drug Submission (SNDS)
  • XANAX; XANAX TSJuly 7, 2022 · NOC 28569 · Supplement to a New Drug Submission (SNDS)
  • LYRICAJune 7, 2022 · NOC 28344 · Supplement to a New Drug Submission (SNDS)
  • GD-AMLODIPINE/ATORVASTATINApril 27, 2022 · NOC 28027 · Supplement to a New Drug Submission (SNDS)
  • DILANTIN INFATABS; DILANTIN-125 SUSPENSION; DILANTIN-30 SUSPENSIONApril 1, 2022 · NOC 27893 · Supplement to a New Drug Submission (SNDS)
  • DILANTINMarch 31, 2022 · NOC 27887 · Supplement to a New Drug Submission (SNDS)
  • CELEBREXMarch 10, 2022 · NOC 27741 · Supplement to a New Drug Submission (SNDS)
  • EFFEXOR XRMarch 3, 2022 · NOC 27699 · Supplement to a New Drug Submission (SNDS)
  • ZELDOXDecember 23, 2021 · NOC 27303 · Supplement to a New Drug Submission (SNDS)
  • LIPITORNovember 12, 2021 · NOC 27019 · Supplement to a New Drug Submission (SNDS)
  • CADUETNovember 12, 2021 · NOC 27020 · Supplement to a New Drug Submission (SNDS)
  • ZOLOFTSeptember 29, 2021 · NOC 26762 · Supplement to a New Drug Submission (SNDS)
  • GD-AMLODIPINE/ATORVASTATINApril 28, 2021 · NOC 25750 · Supplement to a New Drug Submission (SNDS)
  • REVATIOFebruary 25, 2021 · NOC 25284 · Supplement to a New Drug Submission (SNDS)
  • CADUETDecember 10, 2020 · NOC 24775 · Supplement to a New Drug Submission (SNDS)
  • LIPITORDecember 10, 2020 · NOC 24777 · Supplement to a New Drug Submission (SNDS)
  • DETROL LAJuly 13, 2020 · NOC 23887 · New Drug Submission (NDS)
  • DETROLJuly 13, 2020 · NOC 23889 · New Drug Submission (NDS)
  • REVATIOJune 5, 2020 · NOC 23738 · New Drug Submission (NDS)
  • NORVASCMay 28, 2020 · NOC 23685 · Supplement to a New Drug Submission (SNDS)
  • ZOLOFTMay 15, 2020 · NOC 23612 · New Drug Submission (NDS)
  • EFFEXOR XRMay 14, 2020 · NOC 23607 · New Drug Submission (NDS)
  • GD-ELETRIPTANMay 13, 2020 · NOC 23590 · New Drug Submission (NDS)
  • INSPRAMay 13, 2020 · NOC 23596 · New Drug Submission (NDS)
  • DILANTIN INFATABS; DILANTIN-125 SUSPENSION; DILANTIN-30 SUSPENSIONMay 13, 2020 · NOC 23605 · New Drug Submission (NDS)
  • DILANTINMay 13, 2020 · NOC 23606 · New Drug Submission (NDS)
  • GD-LATANOPROST/TIMOLOLMay 11, 2020 · NOC 23581 · New Drug Submission (NDS)
  • LYRICAMay 11, 2020 · NOC 23586 · New Drug Submission (NDS)
  • XALACOMMay 7, 2020 · NOC 23578 · New Drug Submission (NDS)
  • GD-AMLODIPINE/ATORVASTATINMay 6, 2020 · NOC 23567 · New Drug Submission (NDS)
  • RELPAXMay 6, 2020 · NOC 23568 · New Drug Submission (NDS)
  • CELEBREXMay 6, 2020 · NOC 23569 · New Drug Submission (NDS)
  • VIAGRAMay 6, 2020 · NOC 23570 · New Drug Submission (NDS)
  • ZELDOXMay 6, 2020 · NOC 23571 · New Drug Submission (NDS)
  • NEURONTINMay 5, 2020 · NOC 23547 · New Drug Submission (NDS)
  • GD-LATANOPROSTMay 5, 2020 · NOC 23550 · New Drug Submission (NDS)
  • XALATANMay 1, 2020 · NOC 23535 · New Drug Submission (NDS)
  • CADUETMay 1, 2020 · NOC 23539 · New Drug Submission (NDS)
  • XANAX; XANAX TSMay 1, 2020 · NOC 23542 · New Drug Submission (NDS)
  • LIPITORMay 1, 2020 · NOC 23543 · New Drug Submission (NDS)
  • NORVASCApril 29, 2020 · NOC 23526 · New Drug Submission (NDS)